Eaken Matthew John 4
4 · STEPAN CO · Filed Feb 23, 2018
Insider Transaction Report
Form 4
STEPAN COSCL
Eaken Matthew John
VP & Interim CFO
Transactions
- Award
Common Stock
2018-02-21$73.07/sh+94.211$6,884→ 2,230.335 total(indirect: By Trust) - Award
Stock Appreciation Right
2018-02-21+2,585→ 2,585 totalExercise: $72.99From: 2018-12-31Exp: 2028-02-20→ Common Stock (2,585 underlying) - Exercise/Conversion
Common Stock
2018-02-21+1,547→ 4,358.278 total - Award
Performance Shares
2018-02-21+685→ 685 total→ Common Stock (685 underlying) - Exercise/Conversion
Performance Shares
2018-02-21−875→ 0 total→ Common Stock (875 underlying) - Award
Stock Option (Right to Buy)
2018-02-21+862→ 862 totalExercise: $72.99From: 2018-12-31Exp: 2028-02-20→ Common Stock (862 underlying)
Footnotes (4)
- [F1]The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2017.
- [F2]Vests ratably over three years beginning on the date shown.
- [F3]Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2020.
- [F4]Each performance share represents a contingent right to receive one share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2017.